Overall, the ATR gene, located on chromosome 3q23, consisting of 47 exons, was genetically altered in 7.9% of BLCA samples (121 out of 1,527 after excluding 19 duplicate mutations in patients with multiple samples). This evidence concerns the gene ATR and bladder transitional cell carcinoma.